ABCL-404: First Disclosure of Epcoritamab+R-ICE in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Eligible For Autologous Stem Cell Transplantation (ASCT): EPCORE NHL-2

Category Primary study
ConferenceSociety of Hematologic Oncology Thirteenth Annual Meeting
Year 2025
This article has no abstract
Epistemonikos ID: cfa8a933d1e7ba218e6172f31334800242f49b79
First added on: Aug 30, 2025